<DOC>
	<DOCNO>NCT02111837</DOCNO>
	<brief_summary>This multicenter , randomize , double-blind , parallel-group , reference-controlled 4-month pilot safety study evaluate effect specific lipid fractions-enriched infant formula growth infant age 0-4 month . The study test hypothesis growth infant feed specific lipid fractions-enriched infant formula noninferior growth infant feed standard infant formula .</brief_summary>
	<brief_title>Effects Specific Lipid Fractions-enriched Infant Formulae</brief_title>
	<detailed_description />
	<criteria>Healthy newborn infant Infant ≤14 day old day enrollment Gestational age ≥37 week ( full term infant ) Birth weight ≥2500 g ≤4500 g Singleton birth Having obtain his/her parents'/legal representative 's informed consent Having significant prenatal and/or postnatal disease and/or congenital illness malformation may affect normal growth . Infant undergoing antibiotic therapy . Rehospitalization 2 day first 14 day life . Parents expect comply protocol period study participation . Infants currently participate another trial</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Days</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>